How healthcare and biotech startups can avoid common mistakes in a tight funding environment
How healthcare and biotech startups can avoid common mistakes in a tight funding environment
In the fast-paced world of healthcare innovation, even the most promising startups can stumble due to avoidable financial missteps.
From many expert perspectives, we’ll explore the most frequent pitfalls founders encounter and provide practical strategies to help you steer clear of them.
Join us as we equip you with the financial and strategic insights essential for building a resilient and successful healthcare/life science venture.
MODERATOR:
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S.
Chairman of the Board and Chief Medical Officer at BioFactura, Inc. & Chairman and Founder of the Society of Physician Entrepreneurs
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S., has served on the national board and committees of specialty medical societies since he began his practice in Otolaryngology/Facial Plastic Surgery in 1982. He is an Associate Clinical Professor of Surgery at George Washington University School of Health Sciences and an alumnus of the Yale University School of Medicine. Dr. Hausfeld is widely published in the medical literature, is the pioneer of innovative laser surgery techniques, is the author of a lay oriented medical book on snoring and sleep apnea, and has appeared on numerous local and national television and radio shows as a medical expert. Read full profile…
PANEL:
Elizabeth Cho-Fertikh, PhD
Managing Partner, MEDA Ventures
Elizabeth Cho-Fertikh, PhD is Co-founder and Managing Director at the healthcare investor group, MEDA Angels and as Managing Partner at MEDA Ventures. The MEDA Angels Fund has fully deployed its Fund 1 and collectively with its SPVs, has a portfolio of 23 companies, 2 exits and 0 shutdowns. Fund 2 will continue under MEDA Ventures, investing in early stage MedTech and Life Science companies and is utilizing a novel funding vehicle employing a 3rd party validated AI-predictive platform and an insurance element to protect against downside risk to life science investing while increasing the upside. Read full profile…
David Lacki
Principal, Lacki &Company, LLC
David Lacki is Principal of Lacki & Company, LLC, a boutique law firm advising emerging and middle-market companies on corporate growth, investment strategies, and mergers and acquisitions. With more than 30 years of experience, he has worked with Fortune 100 companies, as well as innovative start-up and emerging enterprises in the manufacturing, telecom, software, and high-tech sectors across the U.S., Europe, Latin America, and Asia. Read full profile…
Jack Miner
Chief Investment Officer, TEDCO
Jack Minor is a leading-edge, results-driven leader for venture-stage technology start-up companies with a deep understanding and affinity for the Venture Capital industry. He successfully partners with Research & Development, strategic investors, and investment colleagues to create and communicate the vision and launch strategy to optimize the global success of pipeline assets. Jack is adept at vetting organizations and teams and evaluating investments strategies and measuring results. Read full profile…
Tien Wong
Chairman & CEO, Opus8, Inc.
Mr. Tien Wong is a tech investor, entrepreneur, and CEO. He is Chairman & CEO of Opus8, Inc., a private investment and advisory firm investing in exceptional life science and tech enabled services companies, as well as specializing in raising capital for promising tech companies and alternative investment fund managers. Read full profile…
